S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
S&P 500   4,288.05 (-0.27%)
DOW   33,507.50 (-0.47%)
QQQ   358.27 (+0.07%)
AAPL   171.21 (+0.30%)
MSFT   315.75 (+0.67%)
META   300.21 (-1.23%)
GOOGL   130.86 (-1.10%)
AMZN   127.12 (+0.90%)
TSLA   250.22 (+1.56%)
NVDA   434.99 (+0.95%)
NIO   9.04 (+1.35%)
BABA   86.75 (+1.41%)
AMD   102.82 (+0.06%)
T   15.03 (+0.13%)
F   12.42 (-1.11%)
MU   68.03 (+4.34%)
CGC   0.78 (-3.69%)
GE   110.55 (-1.59%)
DIS   81.06 (+1.16%)
AMC   7.99 (+2.57%)
PFE   33.18 (+3.40%)
PYPL   58.46 (+0.48%)
NFLX   377.60 (+0.33%)
NASDAQ:RARE

Ultragenyx Pharmaceutical (RARE) Insider Trading & Ownership

$35.65
+0.48 (+1.36%)
(As of 09/29/2023 ET)
Compare
Today's Range
$35.27
▼
$36.08
50-Day Range
$34.92
▼
$43.12
52-Week Range
$33.36
▼
$54.98
Volume
453,607 shs
Average Volume
614,098 shs
Market Capitalization
$2.55 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$81.21
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability

Ultragenyx Pharmaceutical (NASDAQ:RARE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.80%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
8
Amount Of
Insider Selling
(Last 12 Months)
$1.28 M
Get RARE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Ultragenyx Pharmaceutical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RARE Insider Buying and Selling by Quarter


Ultragenyx Pharmaceutical Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/7/2023Theodore Alan HuizengaCAOSell2,163$40.80$88,250.40  
9/5/2023Erik HarrisEVPSell6,000$37.96$227,760.00  
9/1/2023Theodore Alan HuizengaCAOSell970$37.15$36,035.50  
6/30/2023Corazon (Corsee) D SandersDirectorSell585$46.76$27,354.60  
6/19/2023Erik HarrisEVPSell305$48.20$14,701.00  
6/8/2023Corazon (Corsee) D SandersDirectorSell1,485$51.65$76,700.25  
5/18/2023John Richard PinionInsiderSell2,012$50.00$100,600.00  
5/4/2023Karah Herdman ParschauerEVPSell4,378$45.00$197,010.00  
3/1/2023Camille L BedrosianEVPSell3,881$45.25$175,615.25  
3/1/2023Dennis Karl HuangInsiderSell389$45.65$17,757.85  
2/28/2023Theodore Alan HuizengaCAOSell639$43.40$27,732.60  
12/21/2022Theodore Alan HuizengaCAOSell2,031$43.96$89,282.76  
10/14/2022Mardi DierCFOSell1,629$40.16$65,420.64  
10/12/2022Mardi DierCFOSell3,484$38.22$133,158.48  
(Data available from 1/1/2013 forward)












RARE Insider Trading Activity - Frequently Asked Questions

Who is on Ultragenyx Pharmaceutical's Insider Roster?

The list of insiders at Ultragenyx Pharmaceutical includes Camille L Bedrosian, Corazon (Corsee) D Sanders, Dennis Karl Huang, Emil D Kakkis, Erik Harris, John Richard Pinion, Karah Herdman Parschauer, Mardi Dier, Theodore Alan Huizenga, Thomas Richard Kassberg, and William Aliski. Learn more on insiders at RARE.

What percentage of Ultragenyx Pharmaceutical stock is owned by insiders?

6.80% of Ultragenyx Pharmaceutical stock is owned by insiders. Learn more on RARE's insider holdings.

Which Ultragenyx Pharmaceutical insiders have been selling company stock?

The following insiders have sold RARE shares in the last 24 months: Camille L Bedrosian ($314,603.61), Corazon (Corsee) D Sanders ($104,054.85), Dennis Karl Huang ($17,757.85), Erik Harris ($439,361.16), John Richard Pinion ($429,304.88), Karah Herdman Parschauer ($520,573.00), Mardi Dier ($751,102.71), Theodore Alan Huizenga ($263,821.46), and Thomas Richard Kassberg ($688,929.81).

How much insider selling is happening at Ultragenyx Pharmaceutical?

Insiders have sold a total of 62,262 Ultragenyx Pharmaceutical shares in the last 24 months for a total of $3,529,509.33 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:RARE) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -